Nebivolol Heumann (Nebivolol)

Nebivolol is a selective β1‑adrenergic blocker that acts on the cardiovascular system to control blood pressure and improve cardiac performance.

• Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk.
• Heart failure: enhances left‑ventricular ejection fraction and reduces symptoms of chronic heart failure.
• Left ventricular dysfunction: improves cardiac output and may delay disease progression.

• Nebivolol selectively antagonizes β1‑adrenergic receptors, decreasing heart rate and myocardial contractility while also stimulating endothelial nitric oxide release, which produces vasodilation. This dual action reduces systemic vascular resistance and lowers arterial pressure, contributing to its antihypertensive and heart‑failure benefits.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Headache: mild to moderate discomfort.
• Dizziness: sensation of light‑headedness, especially on standing.
• Fatigue: generalized tiredness.
• Nausea: upset stomach, sometimes with vomiting.
• Bradycardia: slower than normal heart rate.
• Flushing: transient warmth and redness of the skin.

Serious or Rare Side Effects

• Severe bradycardia: markedly low heart rate requiring medical attention.
• Hypotension: dangerously low blood pressure.
• AV block: impaired electrical conduction in the heart.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Liver injury: elevated liver enzymes or hepatitis.
• Heart failure exacerbation: worsening of cardiac symptoms.

Before initiating therapy, consider the following safety measures.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: use with caution; liver function should be assessed.
• Asthma or COPD: beta‑blockade may precipitate bronchospasm.
• Pregnancy: safety not established; weigh risks and benefits.
• Concomitant antihypertensives: monitor for additive blood‑pressure lowering effects.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes; awareness helps avoid adverse outcomes.

Major Interactions (Avoid)

• Other beta‑blockers: risk of excessive bradycardia and hypotension.
• Potent CYP2D6 inhibitors (e.g., paroxetine, quinidine): increase nebivolol plasma concentrations.
• Calcium‑channel blockers (verapamil, diltiazem): may cause atrioventricular block.

Moderate Interactions (Monitor Closely)

• Diuretics: additive hypotensive effect; monitor blood pressure.
• ACE inhibitors or ARBs: enhanced blood‑pressure reduction; watch for renal function changes.
• Insulin or oral hypoglycemics: may mask hypoglycemia symptoms; adjust glucose monitoring.